Suppr超能文献

使用Eusol-C低温保存介质保存的人类供体角膜进行角膜移植术的回顾性临床结果

Retrospective Clinical Outcomes of Keratoplasty Using Human Donor Corneas Preserved in Eusol-C Hypothermic Storage Medium.

作者信息

Colabelli Gisoldi Rossella Anna Maria, Pocobelli Giulio, Rodella Umberto, Giurgola Laura, Gatto Claudio, Lodato Gemma, Buffon Giacinta, Nucci Carlo, D'Amato Tóthová Jana, Pocobelli Augusto

机构信息

Ophthalmology Unit-Eye Bank of Rome, San Giovanni Addolorata Hospital, 00184 Rome, Italy.

Ophthalmology Unit, Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

出版信息

J Clin Med. 2024 Dec 13;13(24):7606. doi: 10.3390/jcm13247606.

Abstract

To evaluate the clinical outcomes of cornea transplantation (penetrating keratoplasty, Descemet membrane endothelial keratoplasty, Descemet stripping automated endothelial keratoplasty, and deep anterior lamellar keratoplasty) using donor corneas stored in Eusol-C hypothermic storage medium compared to corneas stored in organ-culture. : The clinical outcomes of 92 patients who underwent corneal transplantation with human donor corneas stored in Eusol-C medium at 2-8 °C were retrospectively evaluated. The control group consisted of 169 patients who received corneas organ-cultured at 31 °C. Donor age, sex, death-to-preservation time, and storage time were recorded. Endothelial cell (EC) density (ECD), EC mortality, and EC morphology scores were evaluated during storage in both groups. Complication rates, visual outcomes, and corneal transparency were monitored for up to six months. : The mean storage in Eusol-C time was 7.7 ± 2.5 days, while organ-culture time was 14.2 ± 4.0 days. In the Eusol-C group, ECD was 2398 ± 354 cells/mm, with an average EC morphology score of 3.4 ± 0.7/4. Approximately 28% of the corneas in the Eusol-C group had no EC mortality. In the organ-culture group, ECD was 2256 ± 328 cells/mm, with an average EC morphology score of 3.5 ± 0.5/4, and 42% were devoid of EC mortality. No complications, such as re-bubbling, were observed in both groups during surgery. Transparent corneas were achieved in 81.3% of the Eusol-C group the day after surgery. Mean corrected distance visual acuity (CDVA) at 3 and 6 months was 4.5 ± 4.0/10 and 5.4 ± 3.7/10 for the Eusol-C group and 5.0 ± 2.9/10 and 5.7 ± 2.8/10 for the organ-culture group, with no statistical differences observed between the groups. No graft failure was observed up to three months. Graft rejection occurred in the Eusol-C group and in the organ-culture group in, respectively, one and two cases at the six-month follow-up. : Comparable surgical outcomes were achieved with donor corneas stored in both hypothermic Eusol-C and organ-culture media.

摘要

评估使用保存在优琐尔 - C低温保存介质中的供体角膜进行角膜移植(穿透性角膜移植术、Descemet膜内皮角膜移植术、Descemet剥脱自动内皮角膜移植术和深板层角膜移植术)与保存在器官培养液中的角膜相比的临床结果。:回顾性评估92例接受保存在2 - 8°C优琐尔 - C介质中的人类供体角膜进行角膜移植患者的临床结果。对照组由169例接受保存在31°C器官培养液中的角膜的患者组成。记录供体年龄、性别、死亡至保存时间和保存时间。在两组保存期间评估内皮细胞(EC)密度(ECD)、EC死亡率和EC形态学评分。监测并发症发生率、视力结果和角膜透明度长达六个月。:优琐尔 - C组的平均保存时间为7.7±2.5天,而器官培养液组为14.2±4.0天。在优琐尔 - C组中,ECD为2398±354个细胞/mm²,平均EC形态学评分为3.4±0.7/4。优琐尔 - C组中约28%的角膜无EC死亡。在器官培养液组中,ECD为2256±328个细胞/mm²,平均EC形态学评分为3.5±0.5/4,42%无EC死亡。两组手术期间均未观察到如再形成气泡等并发症。优琐尔 - C组术后第一天81.3%的角膜保持透明。优琐尔 - C组3个月和6个月时的平均矫正远视力(CDVA)分别为4.5±4.0/10和5.4±3.7/10,器官培养液组为5.0±2.9/10和5.7±2.8/10,两组间无统计学差异。三个月内未观察到移植失败。在六个月随访时,优琐尔 - C组和器官培养液组分别有1例和2例发生移植排斥。:保存在低温优琐尔 - C和器官培养液介质中的供体角膜取得了可比的手术结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355d/11677598/abfd78bb654f/jcm-13-07606-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验